Aspen Aerogels (ASPN) director Nieuwoudt received 6,073 shares
Stacy Durbin Nieuwoudt, a director at Aspen Aerogels (ASPN), reported receiving 6,073 Restricted Stock Units (RSUs) and 5,100 stock options as part of annual non-employee director grants. These grants, made on November 4, 2026, will vest on May 13, 2027, or the day before the company's 2027 annual meeting. Following these transactions, Nieuwoudt directly holds 6,073 shares and 5,100 stock options.
Stock, debt and warrants are among Aspen Aerogels (ASPN)'s potential offerings.
Aspen Aerogels (ASPN) has filed an S-3 registration statement to potentially offer up to $150 million in various securities, including common stock, preferred stock, debt securities, warrants, rights, and units. The company intends to use the net proceeds for general corporate purposes, such as working capital, capital expenditures, debt repayment, investments, and acquisitions. This shelf registration allows for future offerings but does not sell any securities at the time of filing.
Aspen Aerogels explosion costs reach $35 million
Aspen Aerogels has disclosed that the explosion at its East Providence, Rhode Island plant in April 2026 has resulted in $35 million in costs. The Massachusetts-based company is working on a turnaround plan, with new orders coming from AI data centers, battery storage facilities, and liquefied natural gas terminals as U.S. electric vehicle demand softens. The article also notes that OSHA found Aspen Aerogels "willfully" risked worker safety.
Aspen Aerogels Q3 2026 Earnings Call Transcript
Aspen Aerogels (NYSE: ASPN) reported strong Q3 2026 results, exceeding revenue and adjusted EBITDA guidance due to robust energy industrial deliveries, increased GM demand, and growing European EV contributions. The company achieved initial revenue in energy storage and data center infrastructure, demonstrating progress in new markets. Aspen is on track for a staged restart of its East Providence manufacturing facility by the first half of 2027 and provided Q4 2026 guidance, expecting continued momentum, particularly in LNG projects and European thermal barriers.
Aspen Aerogels Appoints Stacy Nieuwoudt to Board of Directors
Aspen Aerogels, Inc. (NYSE: ASPN) has appointed Stacy Nieuwoudt to its Board of Directors, effective November 4, 2026. Nieuwoudt brings extensive experience in energy sector investment analysis, asset management, and public company governance, having previously served at Citadel companies and on the boards of ProFrac Holding Corp., enCore Energy Corp., and Independence Contract Drilling. She will serve on Aspen's Audit Committee and Compensation & Leadership Development Committee, aiming to strengthen the board as the company expands its aerogel technology across various markets.
Aspen Aerogels Inc earnings beat by $0.25, revenue topped estimates
Aspen Aerogels Inc (NYSE: ASPN) reported strong third-quarter results, beating analyst estimates with an EPS of $0.11 against a projected $-0.14 and revenue of $85.18M, surpassing the consensus of $71.08M. The company's stock has shown significant year-over-year growth, increasing by 16.79% in the last 12 months, despite a recent -23.20% dip over the past three months. InvestingPro rates Aspen Aerogels Inc's financial health as "good performance," indicating a positive outlook for the company.
Aspen Aerogels Crushes Q3 Estimates, But A Step-Down Q4 Guide And Incident Costs Complicate The Rebound
Aspen Aerogels reported strong Q3 results, significantly beating earnings and revenue estimates due to operational improvements and increased sales in energy industrial and thermal barrier segments. Despite the impressive beat and a positive shift in investor sentiment, the company's Q4 guidance indicates a sequential step down, and lingering incident-related costs are expected to impact GAAP margins and cash flow into 2027. This suggests that while the narrative has improved, the full financial recovery, particularly in GAAP and cash flow, remains a longer-term prospect.
Aspen Aerogels Appoints Stacy Nieuwoudt to Board of Directors
Aspen Aerogels, Inc. (NYSE: ASPN) announced the appointment of Stacy Nieuwoudt to its Board of Directors, effective November 4, 2026. Ms. Nieuwoudt, a private investor with extensive experience as an energy and industrials analyst at Citadel companies, will serve on the Board's Audit Committee and Compensation & Leadership Development Committee. This appointment is expected to bring valuable investor perspective and expertise in governance to Aspen Aerogels as it expands its aerogel technology across various markets.
What Investors Got Wrong About Aspen Aerogels Before The Drop
Aspen Aerogels (NYSE: ASPN) reported disappointing Q2 2026 results, with revenue dropping to US$49.849 million and net margin falling to a 46.7% loss, contrary to investor expectations of cost cuts and rising EV demand. This performance challenged the optimistic outlook that had previously valued the stock higher, leading to a 32.5% loss for investors over the past year. The current narrative for Aspen Aerogels relies on scaling Energy Industrial projects, European EV thermal programs, and emerging battery storage to diversify revenue and achieve positive adjusted EBITDA.
Aspen Aerogels schedules third-quarter results. USD 80 million guide frames Aspen Aerogels stock
Aspen Aerogels (ASPN) has scheduled its third-quarter results for November 5, 2026, before market open, with a conference call at 8:30 a.m. ET. The company's guidance projects third-quarter revenue between USD 65.00 million and USD 80.00 million, and adjusted EBITDA between USD 7.00 million and USD 15.00 million, indicating a potential significant improvement from Q2. This upcoming announcement is a crucial test for the company to demonstrate whether its revenue growth can translate into positive operating earnings.
Aspen Aerogels, Inc. Estimates – BOATS:ASPN
This article provides an overview of Aspen Aerogels, Inc. (ASPN) financial data and analyst estimates available on TradingView. It allows users to explore reported financial data and compare actual results with average, high, and low estimates across various financial statements and valuation metrics. The platform also visualizes trends over time for the company's income statement, balance sheet, and cash flow.
Aspen Aerogels, Inc. Estimates – NYSE:ASPN
This page provides financial estimates for Aspen Aerogels, Inc. (NYSE: ASPN) on TradingView. It allows users to explore reported financial data and analyst estimates across income statements, balance sheets, cash flow statements, and valuation metrics, comparing actual results with average, high, and low estimates and visualizing trends over time. The platform explicitly states that the information is not investment advice and encourages users to conduct their own research.
Aspen Aerogels, Inc. Schedules Third Quarter 2026 Earnings Release and Conference Call
Aspen Aerogels, Inc. (NYSE: ASPN) announced its third-quarter 2026 financial results will be released before market open on Thursday, November 5, 2026. President & CEO Don Young and CFO & Treasurer Grant Thoele will discuss these results during a conference call scheduled for 8:30 a.m. ET on the same day. Shareholders and interested parties can participate by dialing in or accessing a live webcast.
Aspen Aerogels, Inc. Schedules Third Quarter 2026 Earnings Release and Conference Call
Aspen Aerogels, Inc. (NYSE: ASPN) announced its third-quarter 2026 financial results will be released before market open on Thursday, November 5, 2026. President & CEO Don Young and CFO & Treasurer Grant Thoele will discuss these results during a conference call at 8:30 a.m. ET on the same day. Shareholders and interested parties can join the call or access a live webcast and replay through the company's Investors section.
A passive stake exceeds 5% at Aspen Aerogels (ASPN), with AIGH Capital Management reporting ownership.
Orin Hirschman and AIGH Capital Management LLC have reported a passive stake of 8.6% in Aspen Aerogels, Inc. (ASPN), totaling 7,150,126 shares. This disclosure was made via a SCHEDULE 13G filing, indicating that they hold sole voting and dispositive power over these shares. The filing details the beneficial ownership structure and confirms compliance with SEC regulations for passive investments exceeding 5%.
B.Riley reiterates USD 9.00 target for Aspen Aerogels stock
B.Riley has reaffirmed a USD 9.00 price target and a Buy rating for Aspen Aerogels (ASPN) stock, following the company's Q2 revenue of USD 49.85 million against a USD 42.42 million consensus. The analyst's decision is based on meetings with management, focusing on the company's operating recovery and upcoming earnings release. Aspen Aerogels has provided Q3 revenue guidance of USD 65.00-80.00 million and adjusted EBITDA guidance of USD 7.00-15.00 million, indicating an expected sharp operational improvement.
AssetBuilt Announces Major U.S. Industrial Asset Sales
AssetBuilt, a global industrial asset disposition company, announced a series of industrial equipment sales and manufacturing real estate opportunities in October and November 2026. These offerings include four major industrial real estate properties from Cutrale Florida, Aspen Aerogels Georgia, Jindal Films Oklahoma, and Mil-Spec Los Angeles, along with equipment from R3 Lithium and a Fortune 500 EV manufacturer. The sales feature a wide range of assets, from electrical infrastructure and advanced production technology to specialized processing equipment, catering to various industrial sectors.
How (ASPN) Movements Inform Risk Allocation Models
This article analyzes Aspen Aerogels Inc. (ASPN), highlighting a strong overweight bias across all time horizons based on AI models. It details three distinct trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels. The analysis emphasizes an exceptional risk-reward setup, targeting a significant gain with minimal risk.
B.Riley reiterates Buy on Aspen Aerogels stock, $9 target By Investing.com
B.Riley has reiterated a Buy rating and a $9.00 price target for Aspen Aerogels (NYSE: ASPN), following meetings with the company's management. The stock is currently trading at $5.87 and has seen a 107% year-to-date increase, although InvestingPro analysis suggests it may be overvalued. The company anticipates returning to positive adjusted EBITDA in Q3 2026 and expects strong performance from its EV business in the U.S. and Europe, as well as its Energy Industrial and battery energy storage system segments.
B.Riley reiterates Buy on Aspen Aerogels stock, $9 target
B.Riley has reiterated a Buy rating and a $9.00 price target on Aspen Aerogels (NYSE:ASPN) after recent investor meetings, noting the company's strong performance in the EV business and energy industrial drivers. Despite shares being up 107% year-to-date, InvestingPro analysis suggests they are overvalued relative to Fair Value estimates. Aspen Aerogels anticipates returning to positive adjusted EBITDA in Q3 2026 and expects significant revenue growth from battery energy storage systems.
Aspen Aerogels stock gained 3.16 percent after Q2 results
Aspen Aerogels (ASPN) stock rose 3.16% after announcing Q2 revenue of $49.8 million, a 32% increase quarter-over-quarter, and providing a Q3 revenue guide of $65 million-$80 million, indicating significant sequential growth. The company also increased its 2026 European OEM revenue outlook. Despite a Q2 GAAP net loss, the Q3 forecast suggests a potential for positive adjusted EBITDA.
Aspen Aerogels Q2 2026 Earnings Call Transcript
Aspen Aerogels reported strong Q2 2026 financial results with a 32% revenue increase quarter-over-quarter, driven by its PyroThin thermal barrier business. The company provided an optimistic Q3 revenue outlook of $65-$80 million, supported by robust Energy Industrial project deliveries and increased demand for thermal barriers, particularly from European OEMs including a new design award from Jaguar Land Rover. Despite an incident at its East Providence plant, Aspen Aerogels maintains a strong liquidity position and expects full production capacity to be restored by H1 2027, while also exploring Battery Energy Storage Systems as a new growth opportunity.
Cryogenic Pipe Insulants Market Size, Share, Trends 2036
The cryogenic pipe insulants market is projected to reach USD 2,201.7 million by 2036, growing at a 5.5% CAGR from 2026, driven by the increasing construction of LNG and industrial-gas facilities. Cellular glass and LNG pipelines are expected to dominate market share due to their properties and extensive use in cold-service transfer piping. Key countries like Malaysia and South Korea are anticipated to exhibit strong growth, fueled by existing infrastructure and new low-temperature projects.
Aspen Aerogels stock targets positive EBITDA in Q3 guidance
Aspen Aerogels (ASPN) stock is targeting positive adjusted EBITDA in its Q3 2026 guidance, with revenue expected between USD 65 million and USD 80 million. The company's Q2 2026 revenue was USD 49.8 million, showing sequential improvement but still a GAAP net loss. Aspen Aerogels aims for long-term targets including a 35% gross margin and 25% adjusted EBITDA margin, with its next earnings report scheduled for October 22, 2026.
Aspen Aerogels (ASPN) Gets a Buy from Craig-Hallum
Craig-Hallum analyst Eric Stine reiterated a Buy rating on Aspen Aerogels (ASPN) with a price target consensus of $7.25. The company's shares closed at $5.22, and Stine has a 14.3% average return on recommended stocks. Despite a recent decline in revenue and increased GAAP net loss, corporate insider sentiment on the stock is negative due to increased selling activity.
Form 4 Aspen Aerogels Inc For: 24 September By Investing.com
This article reports on a Form 4 filing for Aspen Aerogels Inc., indicating a transaction or change in ownership that occurred on September 24th. The brief piece, published on Investing.com, provides no further details beyond the filing announcement.
Form 4 Aspen Aerogels Inc For: 24 September By Investing.com
This article announces the filing of Form 4 for Aspen Aerogels Inc. on September 24. Form 4 is a U.S. Securities and Exchange Commission (SEC) filing used to report changes in beneficial ownership of a company's securities by insiders. The article indicates that Aspen Aerogels Inc.'s stock symbol is ASPN, and it was trading down 6.69% at the time of publication.
Wood River Capital sells $58.1 million of Aspen Aerogels stock
Wood River Capital, LLC, a significant owner of Aspen Aerogels (NASDAQ:ASPN), has sold 12,280,426 shares for approximately $58.1 million. Following this transaction, Wood River Capital no longer directly holds shares in the company, though beneficial ownership remains with Koch Industries, Inc. through an indirect structure. Despite the stock being up 54% in the last six months, InvestingPro suggests it is overvalued, and the company recently reported a mixed Q2 2026, missing earnings but exceeding revenue expectations.
One block trade left Koch and Wood River with no shares in Aspen Aerogels (ASPN).
Wood River Capital, LLC and Koch, Inc. have reported selling all 12,280,426 of their Public Shares in Aspen Aerogels, Inc. (ASPN) on September 23, 2026, for $4.73 per share in a block trade. Following this transaction, neither entity holds any beneficial ownership in Aspen Aerogels. This transaction marks their complete divestment and cessation as beneficial owners.
Wood River Capital sells $58.1 million of Aspen Aerogels stock By Investing.com
Wood River Capital, LLC, a significant owner of Aspen Aerogels (NASDAQ:ASPN), has sold over 12 million shares for approximately $58.1 million. Following this transaction, Wood River Capital no longer directly holds shares in the company, though beneficial ownership remains with Koch Industries Inc. The sale occurred as Aspen Aerogels' stock experienced high volatility, and its recent Q2 2026 earnings showed a mixed performance with missed earnings expectations but significantly exceeded revenue forecasts.
Aspen Aerogels stock gains 3.65 percent on Q3 guidance
Aspen Aerogels stock saw a 3.65 percent gain in after-hours trading following positive Q3 2026 adjusted EBITDA guidance, ranging from USD 7 million to USD 15 million. This marks a significant improvement from Q2's negative adjusted EBITDA, despite projected net losses. The company reported Q2 revenue of USD 49.849 million and highlighted a production capacity capable of supporting over USD 600 million in annual revenue.
Aspen Aerogels stock edges lower after recent earnings and valuation reset
Aspen Aerogels (ASPN) stock is trading around USD 5.07 as of September 19, 2026, after its recent quarterly figures and a market valuation reset. The company reported continued revenue growth in the first half of 2026 but still posted a net loss due to investments in manufacturing capacity and new customer programs. Analysts see potential upside over the long term but also note risks related to execution and capital expenditure, keeping the stock in the small-cap segment.
These 5 Green Stocks Have Crushed Clean Energy ETFs, S&P 500 And AI Funds In 2026
Five green energy stocks, including Bloom Energy, FuelCell Energy, Vicor Corporation, Aspen Aerogels, and Enlight Renewable Energy, have significantly outperformed clean energy ETFs, the S&P 500, and AI funds in 2026. Bloom Energy led with over 223% gains, while the others also posted strong returns. These companies operate in diverse sectors such as fuel cells, power delivery for AI, renewable energy, and advanced materials for EV batteries.
Positive adjusted profit metric returns for Aspen Aerogels (NYSE: ASPN) even as it guides a Q3 loss
Aspen Aerogels (ASPN) has released an investor presentation outlining its business profile, growth drivers, and financial targets. The company expects to return to positive Adjusted EBITDA in Q3 2026, guiding between $7.0 million and $15.0 million, despite an anticipated net loss of $6.0 million to $9.0 million. Aspen also highlights its capacity to support over $600 million in annual revenue, a 47% reduction in its breakeven revenue target, and a strong intellectual property portfolio.
Form 8K Aspen Aerogels Inc For: 15 September By Investing.com
The article reports on the filing of a Form 8K by Aspen Aerogels Inc. on September 15, 2026. This brief piece, published by Investing.com, simply announces the SEC filing without providing further details about its content. It includes the stock symbol ASPN and its current performance.
Form 8K Aspen Aerogels Inc For: 15 September By Investing.com
Investing.com reported on an 8K filing by Aspen Aerogels Inc for September 15th, 2026. The article itself is very brief, serving primarily as a notification of the SEC filing rather than providing detailed analysis. It includes standard market data and links to other news and analysis.
Form 8K Aspen Aerogels Inc For: 15 September By Investing.com
This article announces that Aspen Aerogels Inc. has filed a Form 8K on September 15. The publication appears to be a standard financial news brief from Investing.com, providing basic details without additional commentary or in-depth analysis.
Aspen Aerogels Share Price - ASPN, RNS News, Articles, Quotes, & Charts (NYSE: ASPN)
This page provides an overview of Aspen Aerogels (NYSE: ASPN), an aerogel technology company specializing in insulation products for energy infrastructure and building materials. It details the company's various product lines, market capitalization ($458.51 million), recent stock performance, and includes links to related news and research. The company, founded in 2001 and headquartered in Northborough, Massachusetts, also engages in contract research for government institutions.
Aspen Aerogels (NYSE:ASPN) Downgraded to "Sell" Rating by Wall Street Zen
Wall Street Zen has downgraded Aspen Aerogels (NYSE:ASPN) from "Hold" to "Sell," despite some analysts maintaining "Buy" ratings and the company exceeding revenue estimates in its latest earnings report. The stock's average rating is now "Hold" with a price target of $5.94, and it continues to face negative profitability metrics. Institutional investors hold a significant majority of the shares.
Needham group (ASPN) discloses 3.26M Aspen Aerogels shares with shared voting power
Needham Investment Management L.L.C., Needham Asset Management, LLC, and George A. Needham have filed an amended Schedule 13G disclosing beneficial ownership of 3,260,800 shares of Aspen Aerogels Inc. (ASPN), representing 3.9% of the outstanding common stock. All reported shares are held with shared voting and dispositive power, and the group disclaims sole beneficial ownership except to the extent of pecuniary interest. This filing indicates their ownership is below the 5% threshold.
Why Did ASPN Stock Plummet 25% Today?
Shares of Aspen Aerogels (ASPN) dropped 25% after the company reported a significant 66% decline in Q4 revenue to $41.3 million, falling short of analyst expectations. The company also posted a net loss of $72.9 million and announced a strategic review to improve its long-term positioning. Aspen Aerogels further provided a weak Q1 FY26 revenue forecast between $35 million and $40 million.
ASPN Maintained by Barclays -- Price Target Raised to $5.00
Barclays has maintained an "Underweight" rating for Aspen Aerogels (ASPN) but raised its price target from $4.00 to $5.00, an increase of 25%. Despite the raised target, analysts express caution due to the stock's 29.1% overvaluation compared to its GF Value™ of $4.81 and its low profitability score of 2/10. The company, which specializes in high-performance aerogel insulation, shows moderate overall performance with a GF Score™ of 67/100 and no insider trading activity in the last three months, suggesting a mixed outlook for investors.
ASPN (ASPN) investor files to sell 5,593 restricted common shares
A shareholder of Aspen Aerogels Inc. (ASPN) has filed to sell 5,593 restricted common shares under Rule 144 through Morgan Stanley Smith Barney LLC. The aggregate market value of these shares is $35,291.83, and they originate from restricted stock grants dated September 13, 2025, and March 5, 2026. This filing indicates a planned sale on the NYSE.
Jaguar Land Rover awards Aspen Aerogels two architectures; production start expected 2027
Aspen Aerogels (NYSE: ASPN) announced its Q2 2026 financial results, reporting total revenue of $49.8 million and a net loss of $23.3 million, impacted by an incident at its East Providence facility. Despite the losses, the company secured a significant PyroThin® award from Jaguar Land Rover for two next-generation vehicle architectures, with production expected to begin in 2027. Aspen Aerogels also provided a positive outlook for Q3 2026, forecasting revenue between $65 million and $80 million and adjusted EBITDA of $7 million to $15 million, while also raising its 2026 European Thermal Barrier revenue outlook.
Aspen Aerogels (ASPN) Stock Forum and Discussion
This article provides a forum for discussion regarding Aspen Aerogels (ASPN) stock. It likely includes general information about the company and its stock performance to facilitate investor conversation.
Aspen Aerogels: Thermal Barrier Revenue Jumps 81% As Jaguar Land Rover Adds Two Next-Generation Vehicle Architectures
Aspen Aerogels reported an 81% sequential increase in Thermal Barrier revenue in Q2 2026, reaching $29.5 million, driven by stabilizing demand in North America and ramping European EV programs. The company also secured a new PyroThin award for two next-generation Jaguar Land Rover vehicle architectures. Despite an incident at its East Providence facility causing an $8.9 million property damage loss, Aspen Aerogels anticipates significant financial improvement in Q3, with projected revenue of $65 million to $80 million and Adjusted EBITDA between $7 million and $15 million.
Aspen Aerogels (NYSE:ASPN) Stock Price Down 11% - Should You Sell?
Aspen Aerogels (NYSE: ASPN) stock dropped 11% despite beating Q2 revenue expectations and offering strong Q3 guidance, primarily due to continued unprofitability and negative margins. While operational momentum, especially in Thermal Barrier revenue, is positive, analysts have a mixed view, resulting in a consensus "Hold" rating and a price target of $5.69. Institutional investors have been adjusting their stakes, indicating cautious optimism amidst the company's growth in electric vehicle and battery materials.
Aspen Aerogels, Inc. Stock 12‑Month Price Target Raised to $6.75, Implies 35% Upside
The 12-month price target for Aspen Aerogels, Inc. (ASPN) stock has been raised to $6.75, up from $6.35, implying a potential 35% upside based on the Aug. 5 closing price. This revised target comes from estimates by five analysts, with forecasts ranging from $4 to $10 per share. The consensus rating for ASPN remains a "Buy" among six covering analysts, with four recommending Buy, one Hold, and one Sell.
Thermal barrier slowdown and plant incident weigh on Aspen Aerogels (NYSE: ASPN)
Aspen Aerogels (ASPN) reported significantly lower financial results for Q2 and the first half of 2026, with revenue declining due to weakened Thermal Barrier demand, particularly from a major EV customer. The company also faced operational challenges and increased costs from incidents at its East Providence manufacturing facility. Despite a net loss, Aspen Aerogels holds $151.7 million in cash and expects to seek additional financing for long-term growth, while maintaining compliance with financial covenants.
Aspen Aerogels Inc (ASPN) (Q2 2026) Earnings Call Highlights: Strong Q3 Outlook and European ...
Aspen Aerogels Inc (ASPN) reported Q2 2026 revenue of $49.8 million, a 32% increase quarter-over-quarter, and provided a strong Q3 2026 revenue outlook of $65 million to $80 million. The company raised its 2026 European Thermal Barrier revenue outlook due to a new Jaguar Land Rover design award and expects continued growth in its Energy Industrial segment. Despite a GAAP net loss and negative adjusted EBITDA in Q2, the company is progressing with its plant restart and developing Battery Energy Storage Systems.